Aurora Spine Corp (TSE:ASG)
:ASG
Want to see TSE:ASG full AI Analyst Report?
ASG Stock Chart & Stats
C$0.28
>-C$0.01(-1.05%)
At close: 4:00 PM EST
C$0.28
>-C$0.01(-1.05%)
Day’s Range― - ―
52-Week RangeC$0.24 - C$0.40
Previous CloseN/A
Volume6.50K
Average Volume (3M)30.19K
Market Cap
C$21.47M
Enterprise ValueC$18.35M
Total Cash (Recent Filing)C$926.33K
Total Debt (Recent Filing)C$3.59M
Price to Earnings (P/E)―
Beta0.23
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding78,054,950
10 Day Avg. Volume38,837
30 Day Avg. Volume30,190
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)4.78
Price to Sales (P/S)1.20
P/FCF Ratio78.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained revenue growth indicates expanding product adoption and market traction for Aurora Spine's implants and tools. Over the next 2–6 months this trend supports scale benefits, helps justify continued investment in R&D and commercialization, and underpins longer-term revenue stability.
Healthy Gross MarginA gross margin above 50% suggests structurally favorable product economics and pricing power in core spinal implant lines. This margin cushion supports investment in product development and sales while insulating operating profit from modest cost pressures, aiding margin sustainability over time.
Moderate LeverageA debt-to-equity around 0.62 denotes manageable leverage and an improvement versus prior periods, giving the company financial flexibility. Moderate debt levels reduce bankruptcy risk and allow borrowing for targeted growth initiatives without immediate balance-sheet stress.
Bears Say
Negative ProfitabilityPersistent negative net income and EBIT margins indicate operational inefficiencies or high fixed costs relative to current sales. Over months this limits retained earnings, reduces ability to self-fund growth, and requires either improved margins or external capital for sustained commercialization.
Weak Cash GenerationLow operating cash conversion and negative free cash flow signal constrained liquidity and poor cash generation from operations. This structural cash weakness increases reliance on financing, can delay product launches or sales expansion, and raises execution risk over the medium term.
Limited Scale And ResourcesA very small employee base limits commercial reach, clinical support and rapid scaling in hospital channels. Over several months this can slow adoption, strain R&D and regulatory initiatives, and increase dependence on partners or distributors to achieve broader market penetration.
Aurora Spine News
ASG FAQ
What was Aurora Spine Corp’s price range in the past 12 months?
Aurora Spine Corp lowest stock price was C$0.23 and its highest was C$0.40 in the past 12 months.
What is Aurora Spine Corp’s market cap?
Aurora Spine Corp’s market cap is C$21.47M.
When is Aurora Spine Corp’s upcoming earnings report date?
Aurora Spine Corp’s upcoming earnings report date is Apr 29, 2026 which is today.
How were Aurora Spine Corp’s earnings last quarter?
Currently, no data Available
Is Aurora Spine Corp overvalued?
According to Wall Street analysts Aurora Spine Corp’s price is currently Overvalued.
Does Aurora Spine Corp pay dividends?
Aurora Spine Corp does not currently pay dividends.
What is Aurora Spine Corp’s EPS estimate?
Aurora Spine Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aurora Spine Corp have?
Aurora Spine Corp has 78,054,950 shares outstanding.
What happened to Aurora Spine Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Aurora Spine Corp?
Currently, no hedge funds are holding shares in TSE:ASG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Aurora Spine Corp
Aurora Spine (ASG) is a medical device company focused on developing innovative spinal implants and surgical solutions. The company operates in the orthopedic and spinal surgery sectors, providing a range of products that include interbody fusion devices, spinal fixation systems, and minimally invasive surgical tools. Aurora Spine aims to improve patient outcomes and enhance surgical efficiency through its advanced technology and commitment to research and development.
Technical Analysis
Perimeter Medical Imaging AI
―
―
Theralase Technologies
―
VentriPoint Diagnostics
―
―
Options Prices
Currently, No data available
---